Skip to main content

Advertisement

SpringerLink
Log in

Diagnostics for Fungal Infections in Solid Organ Transplants (SOT)

  • FUNGAL INFECTIONS IN TRANSPLANTATION (S SHOHAM, SECTION EDITOR)
  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review examined the literature on the diagnosis of invasive fungal disease (IFD) in patients undergoing solid organ transplants (SOT) to describe the diagnostic options available for this cohort.

Recent Findings

The tools available for the diagnosis of IFD in SOT patients are similar to those for patients undergoing stem cell transplants. These include (1) direct visualisation by radiography or histopathology, (2) antigenic tests using ELISA or lateral flow devices for fungal antigens, and (3) PCR-based assays that are commercially available for the two primary IFD affecting SOT patients, aspergillosis and candidiasis. Testing recipients and donors for IFD susceptibility may lead to improved prediction of IFD in SOT.

Summary

The organ being transplanted has a strong bearing on the risk of IFD and the fungi that will cause disease. No single methodology can yield a definitive diagnosis so combinations of diagnostic tests targeted to the specific patient can indicate the probability of IFD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest have been highlighted as: • Of importance •• Of major importance

  1. Segal BH. Aspergillosis. N Engl J Med. 2009;360(18):1870–84. https://doi.org/10.1056/NEJMra0808853.

    Article  CAS  PubMed  Google Scholar 

  2. Hosseini-Moghaddam SM, Ouedraogo A, Naylor KL, Bota SE, Husain S, Nash DM, et al. Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: a population-based cohort study. Transpl Infect Dis. 2020;22(2):e13250. https://doi.org/10.1111/tid.13250.

    Article  PubMed  Google Scholar 

  3. Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol. 2007;45(4):305–20. https://doi.org/10.1080/13693780701200372.

    Article  PubMed  Google Scholar 

  4. Gavalda J, Meije Y, Fortun J, Roilides E, Saliba F, Lortholary O, et al. Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20(Suppl 7):27–48. https://doi.org/10.1111/1469-0691.12660.

    Article  PubMed  Google Scholar 

  5. Singh N, Husain S, Practice ASTIDCo. Aspergillosis in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):228–41. https://doi.org/10.1111/ajt.12115.

    Article  CAS  PubMed  Google Scholar 

  6. Vazquez JA, Miceli MH, Alangaden G. Invasive fungal infections in transplant recipients. Ther Adv Infect Dis. 2013;1(3):85–105. https://doi.org/10.1177/2049936113491936.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Welte T, Len O, Munoz P, Romani L, Lewis R, Perrella A. Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response. Infection. 2019;47(6):919–27. https://doi.org/10.1007/s15010-019-01360-z.

    Article  PubMed  Google Scholar 

  8. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101–11. https://doi.org/10.1086/651262. This was a 5-year study of invasive fungal infections (IFI) in 6 transplant patients in the USA. It determined the incidence of the most common IFIs 7 and the incidence of IFI associated with the transplant of different organs.

    Article  PubMed  Google Scholar 

  9. Anesi JA, Baddley JW. Approach to the solid organ transplant patient with suspected fungal infection. Infect Dis Clin North Am. 2016;30(1):277–96. https://doi.org/10.1016/j.idc.2015.10.001.

    Article  PubMed  Google Scholar 

  10. Kim YJ, Kim SI, Choi JY, Yoon SK, Na GH, You YK, et al. Invasive fungal infection in liver transplant recipients in a prophylactic era: a multicenter retrospective cohort study in Korea. Medicine (Baltimore). 2019;98(26):e16179. https://doi.org/10.1097/MD.0000000000016179.

    Article  Google Scholar 

  11. Lestrade PP, van der Velden W, Bouwman F, Stoop FJ, Blijlevens NMA, Melchers WJG, et al. Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study. J Antimicrob Chemother. 2018;73(5):1389–94. https://doi.org/10.1093/jac/dkx527. This study aimed at determining the incidence of infections by triazole-resistant A. fumigatus in cases of invasive aspergillosis (IA).

    Article  CAS  PubMed  Google Scholar 

  12. Meis JF, Chowdhary A, Rhodes JL, Fisher MC, Verweij PE. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. Philos Trans R Soc Lond B Biol Sci. 2016;371(1709):20150460. https://doi.org/10.1098/rstb.2015.0460.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Farmakiotis D, Kontoyiannis DP. Emerging issues with diagnosis and management of fungal infections in solid organ transplant recipients. Am J Transplant. 2015;15(5):1141–7. https://doi.org/10.1111/ajt.13186. An important review of the use of different diagnostic methods in the detection of IFI in SOT, this also reported on linking diagnosis with antifungal resistance and antifungal stewardship.

    Article  CAS  PubMed  Google Scholar 

  14. Chryssanthou E, Klingspor L, Tollemar J, Petrini B, Larsson L, Christensson B, et al. PCR and other non-culture methods for diagnosis of invasive Candida infections in allogeneic bone marrow and solid organ transplant recipients. Mycoses. 1999;42(4):239–47. https://doi.org/10.1046/j.1439-0507.1999.00451.x.

    Article  CAS  PubMed  Google Scholar 

  15. Vehreschild JJ, Ruping MJ, Steinbach A, Cornely OA. Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients. Expert Opin Pharmacother. 2010;11(1):95–113. https://doi.org/10.1517/14656560903405639.

    Article  PubMed  Google Scholar 

  16. Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–76. https://doi.org/10.1093/cid/ciz1008. This study is extremely significant in diagnosis of IFI, it determines the definitions for classifying cases as having a fungal infection as well as recommendations on the diagnostic tools that should be used.

    Article  PubMed  Google Scholar 

  17. Terrero-Salcedo D, Powers-Fletcher MV. Updates in laboratory diagnostics for invasive fungal infections. J Clin Microbiol. 2020;58(6):e01487-19. https://doi.org/10.1128/JCM.01487-19.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cruciani M, Mengoli C, Barnes R, Donnelly JP, Loeffler J, Jones BL, et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database Syst Rev. 2019;9:CD009551. https://doi.org/10.1002/14651858.CD009551.pub4. This was an extensive analysis of the literature on the use of qPCR for the diagnosis of IA and was able to identify the optimal application of qPCR. It also indicated the negative effects of antifungal prophylaxis on diagnosis.

    Article  PubMed  Google Scholar 

  19. Cruciani M, White PL, Mengoli C, Loffler J, Morton CO, Klingspor L, et al. The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis. J Antimicrob Chemother. 2020. https://doi.org/10.1093/jac/dkaa498.

    Article  Google Scholar 

  20. Kabir V, Maertens J, Kuypers D. Fungal infections in solid organ transplantation: an update on diagnosis and treatment. Transplant Rev (Orlando). 2019;33(2):77–86. https://doi.org/10.1016/j.trre.2018.12.001. This study described risk factors, diagnosis, treatment, and prophylaxis for the main IFIs affecting SOT. The focus on SOT was of great importance. This study described risk factors, diagnosis, treatment, and prophylaxis for the main IFIs affecting SOT. The focus on SOT was of great importance.

    Article  Google Scholar 

  21. Gaston DC, Azar MM. An approach to fungal diagnostics in solid organ transplantation. OBM Transplant. 2018;2(4):037. https://doi.org/10.21926/obm.transplant.1804037.

    Article  Google Scholar 

  22. Lamoth F, Calandra T. Early diagnosis of invasive mould infections and disease. J Antimicrob Chemother. 2017;72(suppl_1):i19–28. https://doi.org/10.1093/jac/dkx030.

    Article  CAS  PubMed  Google Scholar 

  23. Lim C, Seo JB, Park SY, Hwang HJ, Lee HJ, Lee SO, et al. Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation. Clin Radiol. 2012;67(12):1179–86. https://doi.org/10.1016/j.crad.2012.02.018. This study was focused on CT in SOT for IA, this differentiates it from most studies that focus on stem cell transplants.

    Article  CAS  PubMed  Google Scholar 

  24. Chabi ML, Goracci A, Roche N, Paugam A, Lupo A, Revel MP. Pulmonary aspergillosis. Diagn Interv Imaging. 2015;96(5):435–42. https://doi.org/10.1016/j.diii.2015.01.005.

    Article  CAS  PubMed  Google Scholar 

  25. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology. 1985;157(3):611–4. https://doi.org/10.1148/radiology.157.3.3864189.

    Article  CAS  PubMed  Google Scholar 

  26. Hekimoglu K, Haberal M, Serifoglu I, Kirnap M, Haberal M. Diagnostic analysis of computed tomography patterns in patients with invasive pulmonary aspergillosis after solid-organ transplantation. Exp Clin Transplant. 2019;17(Suppl 1):216–9. https://doi.org/10.6002/ect.MESOT2018.P73. This was important for the focus on the use of CT for IA in SOT.

    Article  PubMed  Google Scholar 

  27. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am. 2003;17(1):113–34, viii. https://doi.org/10.1016/s0891-5520(02)00067-3.

    Article  PubMed  Google Scholar 

  28. Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis. 2011;52(9):1144–55. https://doi.org/10.1093/cid/cir122.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Jenks JD, Rawlings SA, Garcia-Vidal C, Koehler P, Mercier T, Prattes J, et al. Immune parameters for diagnosis and treatment monitoring in invasive mold infection. J Fungi (Basel). 2019;5(4):116. https://doi.org/10.3390/jof5040116.

    Article  CAS  Google Scholar 

  30. Arvanitis M, Ziakas PD, Zacharioudakis IM, Zervou FN, Caliendo AM, Mylonakis E. PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance. J Clin Microbiol. 2014;52(10):3731–42. https://doi.org/10.1128/JCM.01365-14.This was significant in validating the approach of the FPCRI in providing standardised protocols for qPCR diagnosis of IA. This also confirmed the twice weekly sampling frequency for molecular diagnostic tests.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Farmakiotis D, Le A, Weiss Z, Ismail N, Kubiak DW, Koo S. False positive bronchoalveolar lavage galactomannan: effect of host and cut-off value. Mycoses. 2019;62(3):204–13. https://doi.org/10.1111/myc.12867. Confirms the possibility for false positive results for respiratory samples and need for adjusted cut-off values in these samples.

    Article  CAS  PubMed  Google Scholar 

  32. White PL, Barnes RA, Springer J, Klingspor L, Cuenca-Estrella M, Morton CO, et al. Clinical performance of aspergillus PCR for testing serum and plasma: a study by the European Aspergillus PCR Initiative. J Clin Microbiol. 2015;53(9):2832–7. https://doi.org/10.1128/JCM.00905-15. This study examined the utility of qPCR for detection of fungal DNA in serum and plasma samples, the standardisation of methods allowed direct comparison to results for detection of fungal DNA in whole blood.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Leeflang MM, Debets-Ossenkopp YJ, Wang J, Visser CE, Scholten RJ, Hooft L, et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev. 2015;2015(12):CD007394. https://doi.org/10.1002/14651858.CD007394.pub2.

    Article  PubMed Central  Google Scholar 

  34. Nalintya E, Kiggundu R, Meya D. Evolution of cryptococcal antigen testing: what is new? Curr Fungal Infect Rep. 2016;10(2):62–7. https://doi.org/10.1007/s12281-016-0256-3.

    Article  PubMed  PubMed Central  Google Scholar 

  35. White PL. Recent advances and novel approaches in laboratory-based diagnostic mycology. Med Mycol. 2019;57(Supplement_3):S259–66. https://doi.org/10.1093/mmy/myy159. This confirmed how well established the serum galactomannan test is in the diagnosis of IFI and the importance of serological methods in diagnosis of IFI.

    Article  CAS  PubMed  Google Scholar 

  36. Johnson GL, Sarker SJ, Nannini F, Ferrini A, Taylor E, Lass-Florl C, et al. Aspergillus-specific lateral-flow device and real-time PCR testing of bronchoalveolar lavage fluid: a combination biomarker approach for clinical diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2015;53(7):2103–8. https://doi.org/10.1128/JCM.00110-15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Er Dedekarginoglu B, Savas Bozbas S, Ulubay G, Oner Eyuboglu F, Haberal M. Culture-positive pulmonary aspergillosis infection: clinical and laboratory features of solid-organ transplant recipients. Exp Clin Transplant. 2017;15(Suppl 1):214–8. https://doi.org/10.6002/ect.mesot2016.P91.

    Article  PubMed  Google Scholar 

  38. Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL. Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest. 2010;138(4):817–24. https://doi.org/10.1378/chest.10-0488.

    Article  PubMed  Google Scholar 

  39. Zou M, Tang L, Zhao S, Zhao Z, Chen L, Chen P, et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS ONE. 2012;7(8):e43347. https://doi.org/10.1371/journal.pone.0043347.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Heng SC, Morrissey O, Chen SC, Thursky K, Manser RL, Nation RL, et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis. Crit Rev Microbiol. 2015;41(1):124–34. https://doi.org/10.3109/1040841X.2013.804033.

    Article  CAS  PubMed  Google Scholar 

  41. Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, Durkin M, et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation. 2007;83(10):1330–6. https://doi.org/10.1097/01.tp.0000263992.41003.33.

    Article  CAS  PubMed  Google Scholar 

  42. Mercier T, Dunbar A, Veldhuizen V, Holtappels M, Schauwvlieghe A, Maertens J, et al. Point of care aspergillus testing in intensive care patients. Crit Care. 2020;24(1):642. https://doi.org/10.1186/s13054-020-03367-7. This tested the use of lateral flow antigen tests for diagnosis of IFI in bronchoalveolar lavage (BAL), these tests are a potentially rapid method for screening patients while more precise tests are being performed.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Hoenigl M, Koidl C, Duettmann W, Seeber K, Wagner J, Buzina W, et al. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J Infect. 2012;65(6):588–91. https://doi.org/10.1016/j.jinf.2012.10.003.

    Article  PubMed  Google Scholar 

  44. Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol. 2008;15(7):1095–105. https://doi.org/10.1128/CVI.00068-08.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Pan Z, Fu M, Zhang J, Zhou H, Fu Y, Zhou J. Diagnostic accuracy of a novel lateral-flow device in invasive aspergillosis: a meta-analysis. J Med Microbiol. 2015;64(7):702–7. https://doi.org/10.1099/jmm.0.000092.

    Article  CAS  PubMed  Google Scholar 

  46. Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S, et al. Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol. 2012;50(1):7–15. https://doi.org/10.1128/JCM.05267-11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Baddley JW, Forrest GN, Practice ASTIDCo. Cryptococcosis in solid organ transplantation—guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13543. https://doi.org/10.1111/ctr.13543.

    Article  PubMed  Google Scholar 

  48. Boulware DR, Rolfes MA, Rajasingham R, von Hohenberg M, Qin Z, Taseera K, et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg Infect Dis. 2014;20(1):45–53. https://doi.org/10.3201/eid2001.130906.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019;57(2):133–50. https://doi.org/10.1093/mmy/myy086.

    Article  PubMed  Google Scholar 

  50. Kidd SE, Chen SC, Meyer W, Halliday CL. A new age in molecular diagnostics for invasive fungal disease: are we ready? Front Microbiol. 2019;10:2903. https://doi.org/10.3389/fmicb.2019.02903. This was a detailed review of the application of molecular methods for the diagnosis of IFI by qPCR and genome sequencing to detecting drug resistance.

    Article  PubMed  Google Scholar 

  51. White PL, Alanio A, Cruciani M, Gorton R, Millon L, Rickerts V, et al. Nucleic acid tools for invasive fungal disease diagnosis. Current Fungal Infetion Reports. 2020;14:76–88. https://doi.org/10.1007/s12281-020-00374-7. A detailed review of qPCR for detecting fungal nucleic acids including detection in paraffin-embedded samples.

    Article  Google Scholar 

  52. White PL, Wingard JR, Bretagne S, Loffler J, Patterson TF, Slavin MA, et al. Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing. Clin Infect Dis. 2015;61(8):1293–303. https://doi.org/10.1093/cid/civ507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. White PL, Bretagne S, Klingspor L, Melchers WJ, McCulloch E, Schulz B, et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol. 2010;48(4):1231–40. https://doi.org/10.1128/JCM.01767-09.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Erman-Daloglu A, Ozhak B, Salim O, Turhan O, Ongut G, Gunseren F, et al. Evaluation of commercially available real-time polymerase chain reaction assays for the diagnosis of invasive aspergillosis in patients with haematological malignancies. Mycopathologia. 2020;185(2):269–77. https://doi.org/10.1007/s11046-020-00424-1.

    Article  CAS  PubMed  Google Scholar 

  55. Rocchi S, Scherer E, Mengoli C, Alanio A, Botterel F, Bougnoux ME, et al. Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: a study by the fungal PCR Initiative and the Modimucor study group. Med Mycol. 2020. https://doi.org/10.1093/mmy/myaa036.

    Article  Google Scholar 

  56. Springer J, Lackner M, Ensinger C, Risslegger B, Morton CO, Nachbaur D, et al. Clinical evaluation of a Mucorales-specific real-time PCR assay in tissue and serum samples. J Med Microbiol. 2016;65(12):1414–21. https://doi.org/10.1099/jmm.0.000375.

    Article  CAS  PubMed  Google Scholar 

  57. Camp I, Spettel K, Willinger B. Molecular methods for the diagnosis of invasive candidiasis. J Fungi (Basel). 2020;6(3):101. https://doi.org/10.3390/jof6030101.

    Article  CAS  Google Scholar 

  58. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60(6):892–9. https://doi.org/10.1093/cid/ciu959.

    Article  CAS  PubMed  Google Scholar 

  59. Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR 3rd, et al. Detecting infections rapidly and easily for candidemia trial, Part 2 (DIRECT2): a prospective, multicenter study of the T2Candida panel. Clin Infect Dis. 2018;66(11):1678–86. https://doi.org/10.1093/cid/cix1095.

    Article  CAS  PubMed  Google Scholar 

  60. Carvalho-Pereira J, Fernandes F, Araujo R, Springer J, Loeffler J, Buitrago MJ, et al. Multiplex PCR based strategy for detection of fungal pathogen DNA in patients with suspected invasive fungal infections. J Fungi (Basel). 2020;6(4):308. https://doi.org/10.3390/jof6040308.

    Article  CAS  Google Scholar 

  61. Morton CO, White PL, Barnes RA, Klingspor L, Cuenca-Estrella M, Lagrou K, et al. Determining the analytical specificity of PCR-based assays for the diagnosis of IA: what is aspergillus? Med Mycol. 2017;55(4):402–13. https://doi.org/10.1093/mmy/myw093.

    Article  CAS  PubMed  Google Scholar 

  62. Garnham K, Halliday CL, Kok J, Jayawardena M, Ahuja V, Green W, et al. Knowledge at what cost? An audit of the utility of panfungal PCR performed on bronchoalveolar lavage fluid specimens at a tertiary mycology laboratory. Pathology. 2020;52(5):584–8. https://doi.org/10.1016/j.pathol.2020.03.013. This study examined the cost of implementing PCR for the detection of IFI in BAL, finding a high cost that could reduce the availability of this methodology in many settings.

    Article  CAS  PubMed  Google Scholar 

  63. Jia B, Lovari R, Miller H, Metzgar D, Massire C, Carolan H, et al. Evaluation of a PCR-electrospray ionization mass spectrometry platform for detection and identification of fungal pathogens directly from prospectively collected bronchoalveolar lavage specimens. Diagn Microbiol Infect Dis. 2020;97(1):114988. https://doi.org/10.1016/j.diagmicrobio.2020.114988.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Patel R. A moldy application of MALDI: MALDI-ToF mass spectrometry for fungal identification. J Fungi (Basel). 2019;5(1):4. https://doi.org/10.3390/jof5010004.

    Article  CAS  Google Scholar 

  65. Cornu M, Sendid B, Mery A, Francois N, Mikulska M, Letscher-Bru V, et al. Evaluation of mass spectrometry-based detection of panfungal serum disaccharide for diagnosis of invasive fungal infections: results from a collaborative study involving six European clinical centers. J Clin Microbiol. 2019;57(5):e01867-18. https://doi.org/10.1128/JCM.01867-18. Describes a novel test for the diagnosis of IFI by using mass spectrometry for a fungal specific molecule, this test performed well in comparison to established tests and is an innovation in diagnosis of IFI.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Mery A, Sendid B, Francois N, Cornu M, Poissy J, Guerardel Y, et al. Application of mass spectrometry technology to early diagnosis of invasive fungal infections. J Clin Microbiol. 2016;54(11):2786–97. https://doi.org/10.1128/JCM.01655-16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. El-Kamand S, Papanicolaou A, Morton CO. The use of whole genome and next-generation sequencing in the diagnosis of invasive fungal disease. Current Fungal Infection Reports. 2019;13(4):284–91. https://doi.org/10.1007/s12281-019-00363-5.

    Article  Google Scholar 

  68. Venkatappa TK, Punnoose R, Katz DJ, Higgins MP, Banaei N, Graviss EA, et al. Comparing QuantiFERON-TB gold plus with other tests to diagnose mycobacterium tuberculosis infection. J Clin Microbiol. 2019;57(11):e00985-19. https://doi.org/10.1128/JCM.00985-19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Heldt S, Eigl S, Prattes J, Flick H, Rabensteiner J, Pruller F, et al. Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis. Mycoses. 2017;60(12):818–25. https://doi.org/10.1111/myc.12679.

    Article  CAS  PubMed  Google Scholar 

  70. Rawlings SA, Heldt S, Prattes J, Eigl S, Jenks JD, Flick H, et al. Using Interleukin 6 and 8 in blood and bronchoalveolar lavage fluid to predict survival in hematological malignancy patients with suspected pulmonary mold infection. Front Immunol. 2019;10:1798. https://doi.org/10.3389/fimmu.2019.01798.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Goncalves SM, Lagrou K, Rodrigues CS, Campos CF, Bernal-Martinez L, Rodrigues F, et al. Evaluation of bronchoalveolar lavage fluid cytokines as biomarkers for invasive pulmonary aspergillosis in at-risk patients. Front Microbiol. 2017;8:2362. https://doi.org/10.3389/fmicb.2017.02362.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Drummond RA, Lionakis MS. Mechanistic insights into the role of C-type lectin receptor/CARD9 signaling in human antifungal immunity. Front Cell Infect Microbiol. 2016;6:39. https://doi.org/10.3389/fcimb.2016.00039. Direct diagnosis of IFI is challenging so an alternative approach is to monitor the host for indications of fungal disease. CARD9 is important in susceptibility to IFI and this article describes how mutations in this gene are connected to susceptibility to IFI and this provides an avenue for testing patients for susceptibility to IFI prior to transplant.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Sánchez-Maldonado JM, Moñiz-Díez A, Ter Horst R, Campa D, Cabrera-Serrano AJ, Martínez-Bueno M, et al. Polymorphisms within the TNFSF4 and MAPKAPK2 loci influence the risk of developing invasive aspergillosis: a two-stage case control study in the context of the aspBIOmics consortium. J Fungi (Basel). 2020;7(1):4. https://doi.org/10.3390/jof7010004.

    Article  CAS  Google Scholar 

  74. Loeffler J, Ok M, Morton OC, Mezger M, Einsele H. Genetic polymorphisms in the cytokine and chemokine system: their possible importance in allogeneic stem cell transplantation. Curr Top Microbiol Immunol. 2010;341:83–96. https://doi.org/10.1007/82_2010_22.

    Article  CAS  PubMed  Google Scholar 

  75. Maskarinec SA, Johnson MD, Perfect JR. Genetic Susceptibility to Fungal Infections: What is in the Genes? Curr Clin Microbiol Rep. 2016;3(2):81–91. https://doi.org/10.1007/s40588-016-0037-3.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Pana ZD, Farmaki E, Roilides E. Host genetics and opportunistic fungal infections. Clin Microbiol Infect. 2014;20(12):1254–64. https://doi.org/10.1111/1469-0691.12800.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Science, Western Sydney University, Campbelltown Campus, Campbelltown, NSW, 2560, Australia

    Colin M. Stack & C. Oliver Morton

Authors
  1. Colin M. Stack
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Oliver Morton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Oliver Morton.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Fungal Infections in Transplantation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stack, C.M., Morton, C.O. Diagnostics for Fungal Infections in Solid Organ Transplants (SOT). Curr Fungal Infect Rep 15, 127–135 (2021). https://doi.org/10.1007/s12281-021-00422-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-021-00422-w

Keywords

Search

Navigation